- Home
- CENN vs HOOK Comparison
CENN vs HOOK Comparison
Compare CENN & HOOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CENN
- HOOK
- Stock Information
- Founded
- CENN 2013
- HOOK 2011
- Country
- CENN United States
- HOOK United States
- Employees
- CENN N/A
- HOOK N/A
- Industry
- CENN Auto Manufacturing
- HOOK Biotechnology: Pharmaceutical Preparations
- Sector
- CENN Consumer Discretionary
- HOOK Health Care
- Exchange
- CENN Nasdaq
- HOOK Nasdaq
- Market Cap
- CENN 35.8M
- HOOK 36.9M
- IPO Year
- CENN N/A
- HOOK 2019
- Fundamental
- Price
- CENN $1.36
- HOOK $3.17
- Analyst Decision
- CENN
- HOOK Strong Buy
- Analyst Count
- CENN 0
- HOOK 4
- Target Price
- CENN N/A
- HOOK $39.25
- AVG Volume (30 Days)
- CENN 102.0K
- HOOK 49.9K
- Earning Date
- CENN 11-12-2024
- HOOK 11-22-2024
- Dividend Yield
- CENN N/A
- HOOK N/A
- EPS Growth
- CENN N/A
- HOOK N/A
- EPS
- CENN N/A
- HOOK N/A
- Revenue
- CENN $37,052,841.00
- HOOK $52,163,000.00
- Revenue This Year
- CENN N/A
- HOOK $155.36
- Revenue Next Year
- CENN N/A
- HOOK N/A
- P/E Ratio
- CENN N/A
- HOOK N/A
- Revenue Growth
- CENN 142.48
- HOOK 227.80
- 52 Week Low
- CENN $1.00
- HOOK $3.11
- 52 Week High
- CENN $25.00
- HOOK $11.30
- Technical
- Relative Strength Index (RSI)
- CENN 58.62
- HOOK 32.13
- Support Level
- CENN $1.30
- HOOK $3.34
- Resistance Level
- CENN $1.30
- HOOK $3.84
- Average True Range (ATR)
- CENN 0.07
- HOOK 0.21
- MACD
- CENN 0.01
- HOOK -0.01
- Stochastic Oscillator
- CENN 50.00
- HOOK 10.39
About CENN Cenntro Electric Group Limited
Cenntro Inc is a designer, manufacturer, distributor, and service provider of commercial vehicles. Its vehicles include Metro, Logistar 400, Logistar 200, Neibor 200, and ORV. The company's geographical segments include Europe, America, and Asia.
About HOOK HOOKIPA Pharma Inc.
HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies.